A unifying review of deep and shallow anomaly detection

L Ruff, JR Kauffmann, RA Vandermeulen… - Proceedings of the …, 2021 - ieeexplore.ieee.org
Deep learning approaches to anomaly detection (AD) have recently improved the state of
the art in detection performance on complex data sets, such as large collections of images or …

Impact of sex and gender on COVID-19 outcomes in Europe

C Gebhard, V Regitz-Zagrosek, HK Neuhauser… - Biology of sex …, 2020 - Springer
Abstract Background Emerging evidence from China suggests that coronavirus disease
2019 (COVID-19) is deadlier for infected men than women with a 2.8% fatality rate being …

Somatic genomic testing in patients with metastatic or advanced cancer: ASCO provisional clinical opinion

D Chakravarty, A Johnson, J Sklar… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE An ASCO provisional clinical opinion offers timely clinical direction to ASCO's
membership following publication or presentation of potentially practice-changing data from …

[HTML][HTML] Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N= 4532)

M Montopoli, S Zumerle, R Vettor, M Rugge, M Zorzi… - Annals of …, 2020 - Elsevier
Background Cell entry of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
depends on binding of the viral spike (S) proteins to angiotensin-converting enzyme 2 and …

Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities

LA Bienvenu, J Noonan, X Wang… - Cardiovascular …, 2020 - academic.oup.com
The high mortality rate of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
infection is a critical concern of the coronavirus disease 2019 (COVID-19) pandemic …

Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

E Rheinbay, MM Nielsen, F Abascal, JA Wala… - Nature, 2020 - nature.com
The discovery of drivers of cancer has traditionally focused on protein-coding genes,,–. Here
we present analyses of driver point mutations and structural variants in non-coding regions …

Targeting transcription factors in cancer—from undruggable to reality

JH Bushweller - Nature Reviews Cancer, 2019 - nature.com
Mutated or dysregulated transcription factors represent a unique class of drug targets that
mediate aberrant gene expression, including blockade of differentiation and cell death gene …

Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods

BJ Haas, A Dobin, B Li, N Stransky, N Pochet, A Regev - Genome biology, 2019 - Springer
Background Accurate fusion transcript detection is essential for comprehensive
characterization of cancer transcriptomes. Over the last decade, multiple bioinformatic tools …

Human organoids: tools for understanding biology and treating diseases

F Schutgens, H Clevers - Annual Review of Pathology …, 2020 - annualreviews.org
Organoids are in vitro–cultured three-dimensional structures that recapitulate key aspects of
in vivo organs. They can be established from pluripotent stem cells and from adult stem …

[HTML][HTML] Genomic hallmarks and structural variation in metastatic prostate cancer

DA Quigley, HX Dang, SG Zhao, P Lloyd, R Aggarwal… - Cell, 2018 - cell.com
While mutations affecting protein-coding regions have been examined across many
cancers, structural variants at the genome-wide level are still poorly defined. Through …